Kim M. Clark-Langone

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

Richard Gray, Philip Quirke, Kelly Handley et al. · Journal of Clinical Oncology · 2011 · 369 citations · Full text

Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor–Positive Breast Cancer

Maureen Cronin, Chithra Sangli, Mei‐Lan Liu et al. · Clinical Chemistry · 2007 · 344 citations · Full text

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

Dejan Knezevic, Audrey D. Goddard, Nisha Natraj et al. · BMC Genomics · 2013 · 323 citations · Full text

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

Michael J. O’Connell, Ian C. Lavery, Greg Yothers et al. · Journal of Clinical Oncology · 2010 · 298 citations

Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581

Alan P. Venook, Donna Niedzwiecki, Margarita Lopatin et al. · Journal of Clinical Oncology · 2013 · 174 citations · Full text